Which is better, CAMX.ST or IRMD?

On the Buffett-Fit framework, Camurus AB (publ) (CAMX.ST) currently grades higher than IRMD — 78/100 (B grade) vs 68/100 (B). That said, "better" depends on which framework you trust — CAMX.ST wins on Warren Buffett, Benjamin Graham, Philip Fisher, and Terry Smith; IRMD wins on Peter Lynch, Joel Greenblatt, and Charlie Munger. The full pillar breakdown is on this page.

Should I buy CAMX.ST or IRMD?

This page is an educational comparison, not investment advice. Both CAMX.ST and IRMD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is CAMX.ST better than IRMD for value investing?

On the Buffett-style value-investing framework, CAMX.ST currently grades higher — 78/100 vs 68/100, a 10-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between CAMX.ST and IRMD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). CAMX.ST currently scores 78/100 (B grade); IRMD scores 68/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, CAMX.ST or IRMD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. CAMX.ST and IRMD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, CAMX.ST or IRMD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are CAMX.ST and IRMD both Healthcare stocks?

Yes — both Camurus AB (publ) (CAMX.ST) and IRadimed Corporation (IRMD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this CAMX.ST vs IRMD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Camurus AB (publ)

CAMX.ST$36.93BHealthcare Market cap, Sector

IRadimed

IRMD$1.21BHealthcare Market cap, Sector

Overall winner

Camurus AB (publ)

CAMX.ST 43 IRMD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

CAMX.ST4wins

3winsIRMD

Warren Buffett

78B

C68

Benjamin Graham

91A

A89

Philip Fisher

94A

A92

Peter Lynch

65C

B76

Joel Greenblatt

63C

C65

Charlie Munger

77B

B78

Terry Smith

77B

B75

Side-by-side metrics

Metric	CAMX.ST	IRMD
Market cap	Winner: $36.93B	$1.21B
P/E (TTM)	Winner: 42.6x	50.4x
EV/EBIT	Winner: 29.5x	43.4x
ROIC (TTM)	17.17%	21.38% Winner
Gross margin	Winner: 93.11%	76.84%
Net margin	Winner: 32.47%	27.36%
Revenue CAGR 5y	Winner: 33.3%	18.99%
EPS CAGR 5y	Winner: 132.79%	23.53%
Debt / Equity	0.0x	- Winner
Dividend yield	-	1.33%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

CAMX.ST leads on

Market cap$36.93Bvs $1.21B+97%
EPS CAGR 5y132.79%vs 23.53%+82%
Revenue CAGR 5y33.3%vs 18.99%+43%
EV/EBIT29.5xvs 43.4x+32%

IRMD leads on

Debt / Equity-vs 0.0x+100%
ROIC (TTM)21.38%vs 17.17%+20%

More like CAMX.ST

CAMX.ST vs 1681.HK CAMX.ST vs SANOFICONR.NS CAMX.ST vs PME.AX CAMX.ST vs SANOFICONR.BO

More like IRMD

IRMD vs 1681.HK IRMD vs SANOFICONR.NS IRMD vs PME.AX IRMD vs SANOFICONR.BO

Read the full Buffett-Brain analysis for CAMX.ST Read the full Buffett-Brain analysis for IRMD

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Camurus AB (publ)

CAMX.ST$36.93BHealthcare Market cap, Sector

IRadimed

IRMD$1.21BHealthcare Market cap, Sector

Overall winner

Camurus AB (publ)

CAMX.ST 43 IRMD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

CAMX.ST4wins

3winsIRMD

Warren Buffett

78B

C68

Benjamin Graham

91A

A89

Philip Fisher

94A

A92

Peter Lynch

65C

B76

Joel Greenblatt

63C

C65

Charlie Munger

77B

B78

Terry Smith

77B

B75

Side-by-side metrics

Metric	CAMX.ST	IRMD
Market cap	Winner: $36.93B	$1.21B
P/E (TTM)	Winner: 42.6x	50.4x
EV/EBIT	Winner: 29.5x	43.4x
ROIC (TTM)	17.17%	21.38% Winner
Gross margin	Winner: 93.11%	76.84%
Net margin	Winner: 32.47%	27.36%
Revenue CAGR 5y	Winner: 33.3%	18.99%
EPS CAGR 5y	Winner: 132.79%	23.53%
Debt / Equity	0.0x	- Winner
Dividend yield	-	1.33%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

CAMX.ST leads on

Market cap$36.93Bvs $1.21B+97%
EPS CAGR 5y132.79%vs 23.53%+82%
Revenue CAGR 5y33.3%vs 18.99%+43%
EV/EBIT29.5xvs 43.4x+32%

IRMD leads on

Debt / Equity-vs 0.0x+100%
ROIC (TTM)21.38%vs 17.17%+20%

More like CAMX.ST

CAMX.ST vs 1681.HK CAMX.ST vs SANOFICONR.NS CAMX.ST vs PME.AX CAMX.ST vs SANOFICONR.BO

More like IRMD

IRMD vs 1681.HK IRMD vs SANOFICONR.NS IRMD vs PME.AX IRMD vs SANOFICONR.BO

Read the full Buffett-Brain analysis for CAMX.ST Read the full Buffett-Brain analysis for IRMD

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.